chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Nausea
Clinical narrative: nausea; pain at injection; headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), INJECTION SITE PAIN (pain at injection) and HEADACHE (headache) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced NAUSEA (nausea), INJECTION SITE PAIN (pain at injection) and HEADACHE (headache). On 05-Feb-2021, NAUSEA (nausea), INJECTION SITE PAIN (pain at injection) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    Concomitant medications includes Tylenol and Antibiotic. Treatment information included Dentist Prescription:Tylenol every 6 hours Caller only took 2 Antibiotic
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood immunoglobulin E, Pain in extremity
Clinical narrative: arm was hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was hurting) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042620A and 201621A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy since 31-May-1969, Allergy to antibiotic (Tetracycline) since 12-Jan-1976 and Drug allergy (Aspirin) since 14-Dec-1977.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was hurting). At the time of the report, PAIN IN EXTREMITY (arm was hurting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, Blood immunoglobulin E: increased by 25% (High) IgE level had increased by 25%. On 11-Feb-2021, Blood immunoglobulin E: gone up by 30% (High) measure for allergen gone up by 30% then previous count.         Concomitant products included unspecified medications for blood pressure, for cholesterol management and for lungs medication. It was reported that 2 months later the patient remeasured and his IgE counts had come down.  Treatment details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: Follow up received, Added allergy information,patient demographic,lab data, suspect dosage information; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: tongue numbness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (tongue numbness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA ORAL (tongue numbness). At the time of the report, HYPOAESTHESIA ORAL (tongue numbness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter. Treatment information was not provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Nausea
Clinical narrative: Chills; Dizziness; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), DIZZINESS (Dizziness), HEADACHE (Headache) and NAUSEA (Nausea) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced CHILLS (Chills), DIZZINESS (Dizziness), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, CHILLS (Chills), DIZZINESS (Dizziness), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Malaise, Nasal congestion
Clinical narrative: felt ill; Headaches and body aches; sore throat; runny and stuffy nose; runny and stuffy nose; weakness; fatigue and feels tired when talks; Headaches and body aches; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (felt ill), PAIN (Headaches and body aches), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny and stuffy nose) and NASAL CONGESTION (runny and stuffy nose) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced MALAISE (felt ill), PAIN (Headaches and body aches), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny and stuffy nose), NASAL CONGESTION (runny and stuffy nose), ASTHENIA (weakness), FATIGUE (fatigue and feels tired when talks) and HEADACHE (Headaches and body aches). At the time of the report, MALAISE (felt ill), PAIN (Headaches and body aches), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny and stuffy nose), NASAL CONGESTION (runny and stuffy nose), ASTHENIA (weakness), FATIGUE (fatigue and feels tired when talks) and HEADACHE (Headaches and body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants were reported. No treatment was reported.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Rhinorrhoea
Clinical narrative: felt ill; Headaches and body aches; sore throat; runny and stuffy nose; runny and stuffy nose; weakness; fatigue and feels tired when talks; Headaches and body aches; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (felt ill), PAIN (Headaches and body aches), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny and stuffy nose) and NASAL CONGESTION (runny and stuffy nose) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced MALAISE (felt ill), PAIN (Headaches and body aches), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny and stuffy nose), NASAL CONGESTION (runny and stuffy nose), ASTHENIA (weakness), FATIGUE (fatigue and feels tired when talks) and HEADACHE (Headaches and body aches). At the time of the report, MALAISE (felt ill), PAIN (Headaches and body aches), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny and stuffy nose), NASAL CONGESTION (runny and stuffy nose), ASTHENIA (weakness), FATIGUE (fatigue and feels tired when talks) and HEADACHE (Headaches and body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants were reported. No treatment was reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Chest area started itching continuously until above the stomach and also his back but mainly the upper chest/hasn't slept from the itching; Little rash on the chest area; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Chest area started itching continuously until above the stomach and also his back but mainly the upper chest/hasn't slept from the itching) and RASH (Little rash on the chest area) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE, LISINOPRIL and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PRURITUS (Chest area started itching continuously until above the stomach and also his back but mainly the upper chest/hasn't slept from the itching) and RASH (Little rash on the chest area). At the time of the report, PRURITUS (Chest area started itching continuously until above the stomach and also his back but mainly the upper chest/hasn't slept from the itching) and RASH (Little rash on the chest area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications Amlodipine, Lisinopril, Lipitor Treatment details were not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen limph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen limph nodes) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced LYMPHADENOPATHY (Swollen limph nodes). At the time of the report, LYMPHADENOPATHY (Swollen limph nodes) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular, Symptom masked, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Symptoms woke her up in the middle of the night; Bad Rash on the Injection Site; Pain on the Injection Site; Itchy Injection Site; Big Blotch on the Injection Site; Rash on her face; This spontaneous case was reported by a consumer and describes the occurrence of SYMPTOM MASKED (Symptoms woke her up in the middle of the night), RASH MACULAR (Big Blotch on the Injection Site), RASH (Rash on her face), VACCINATION SITE RASH (Bad Rash on the Injection Site) and VACCINATION SITE PAIN (Pain on the Injection Site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced RASH MACULAR (Big Blotch on the Injection Site), RASH (Rash on her face), VACCINATION SITE PAIN (Pain on the Injection Site) and VACCINATION SITE PRURITUS (Itchy Injection Site). On 09-Feb-2021, the patient experienced SYMPTOM MASKED (Symptoms woke her up in the middle of the night) and VACCINATION SITE RASH (Bad Rash on the Injection Site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SYMPTOM MASKED (Symptoms woke her up in the middle of the night), RASH MACULAR (Big Blotch on the Injection Site), RASH (Rash on her face), VACCINATION SITE RASH (Bad Rash on the Injection Site), VACCINATION SITE PAIN (Pain on the Injection Site) and VACCINATION SITE PRURITUS (Itchy Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Symptoms woke her up in the middle of the night; Bad Rash on the Injection Site; Pain on the Injection Site; Itchy Injection Site; Big Blotch on the Injection Site; Rash on her face; This spontaneous case was reported by a consumer and describes the occurrence of SYMPTOM MASKED (Symptoms woke her up in the middle of the night), RASH MACULAR (Big Blotch on the Injection Site), RASH (Rash on her face), VACCINATION SITE RASH (Bad Rash on the Injection Site) and VACCINATION SITE PAIN (Pain on the Injection Site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced RASH MACULAR (Big Blotch on the Injection Site), RASH (Rash on her face), VACCINATION SITE PAIN (Pain on the Injection Site) and VACCINATION SITE PRURITUS (Itchy Injection Site). On 09-Feb-2021, the patient experienced SYMPTOM MASKED (Symptoms woke her up in the middle of the night) and VACCINATION SITE RASH (Bad Rash on the Injection Site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SYMPTOM MASKED (Symptoms woke her up in the middle of the night), RASH MACULAR (Big Blotch on the Injection Site), RASH (Rash on her face), VACCINATION SITE RASH (Bad Rash on the Injection Site), VACCINATION SITE PAIN (Pain on the Injection Site) and VACCINATION SITE PRURITUS (Itchy Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Inflammation
Clinical narrative: inflammation; redness on the arm lingering and lingering; it was a hot spot; This spontaneous case was reported by a health care professional and describes the occurrence of ERYTHEMA (redness on the arm lingering and lingering), FEELING HOT (it was a hot spot) and INFLAMMATION (inflammation) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Hydroxychloroquine.). Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and CALCIUM for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced ERYTHEMA (redness on the arm lingering and lingering) and FEELING HOT (it was a hot spot). On an unknown date, the patient experienced INFLAMMATION (inflammation). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CEPHALEXIN [CEFALEXIN] at a dose of 215 mg. On 25-Jan-2021, ERYTHEMA (redness on the arm lingering and lingering), FEELING HOT (it was a hot spot) and INFLAMMATION (inflammation) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications baby aspirin, Calcium
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Somnolence
Clinical narrative: headache; fever; all she wanted to do was sleep; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PYREXIA (fever) and SOMNOLENCE (all she wanted to do was sleep) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Hypertension. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced HEADACHE (headache), PYREXIA (fever) and SOMNOLENCE (all she wanted to do was sleep). On 06-Feb-2021, HEADACHE (headache), PYREXIA (fever) and SOMNOLENCE (all she wanted to do was sleep) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications High blood pressure medication, Synthroid Treatment details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Vaccination site erythema; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Vaccination site erythema). At the time of the report, VACCINATION SITE ERYTHEMA (Vaccination site erythema) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nasal congestion
Clinical narrative: Stuffy nose; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Stuffy nose) and HEADACHE (Headache) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced NASAL CONGESTION (Stuffy nose) and HEADACHE (Headache). On 25-Jan-2021, NASAL CONGESTION (Stuffy nose) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: didn't really noticed until the next dayor so when got a red rash, it don't hurt, it don't hurt according to the patient. The rash is about 6 to 7 inches long; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (didn't really noticed until the next dayor so when got a red rash, it don't hurt, it don't hurt according to the patient. The rash is about 6 to 7 inches long) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included RALOXIFENE, LOSARTAN and AMLODIPINE for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (didn't really noticed until the next day or so when got a red rash, it don't hurt, it don't hurt according to the patient. The rash is about 6 to 7 inches long). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ITCH) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (didn't really noticed until the next day or so when got a red rash, it don't hurt, it don't hurt according to the patient. The rash is about 6 to 7 inches long) outcome was unknown.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications Blood pressure medicine, Relaoxafine, Losartine, Amlopadine. Treatment details Benadryl on topic and Benadryl pill
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Severe side effects; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Severe side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Severe side effects). At the time of the report, ADVERSE EVENT (Severe side effects) outcome was unknown.            Concomitant medications were not provided. Treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Electric shock sensation, Palpitations
Clinical narrative: Rapid heartbeat; Humming feeling throughout the body; Weakness; Severe chills; A spontaneous report was received from a consumer concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events severe chills, humming feeling throughout the body, weakenss, rapid heartbeat.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 028L20A) Intramuscularly in right armor prophylaxis of COVID-19 infection.  On 9 Feb 2021, the patient experienced the events severe chills, humming feeling throughout the body, weakenss, rapid heartbeat.She has reached out to few of her MD and they have advised her to wait and monitor the side effects.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, severe chills, humming feeling throughout the body, weakenss, rapid heartbeat were unknown.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Nausea
Clinical narrative: Headache after 1st dose; Chills after 1st dose; Dizziness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), NAUSEA (Nausea), HEADACHE (Headache after 1st dose) and CHILLS (Chills after 1st dose) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No medical history information was provided.  Concomitant products included DILTIAZEM HYDROCHLORIDE (DILT-XR) for Blood pressure, ROSUVASTATIN for Cholesterol, NINTEDANIB ESILATE (OFEV) for Lung disorder NOS, ASPIRIN [ACETYLSALICYLIC ACID] and NIACIN for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced DIZZINESS (Dizziness) and NAUSEA (Nausea). On an unknown date, the patient experienced HEADACHE (Headache after 1st dose) and CHILLS (Chills after 1st dose). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Chills, at a dose of UNK, bid. At the time of the report, DIZZINESS (Dizziness), NAUSEA (Nausea), HEADACHE (Headache after 1st dose) and CHILLS (Chills after 1st dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-250340 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up information received: Added events, medical history and treatment.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Pain, Vaccination site pain
Clinical narrative: ache; Arm was very uncomfortable again; Sore arm at injection site and pains; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Arm was very uncomfortable again), PAIN (ache) and VACCINATION SITE PAIN (Sore arm at injection site and pains) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore arm at injection site and pains). On 15-Feb-2021, the patient experienced DISCOMFORT (Arm was very uncomfortable again). On 16-Feb-2021, the patient experienced PAIN (ache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at a dose of 1 dosage form. At the time of the report, DISCOMFORT (Arm was very uncomfortable again), PAIN (ache) and VACCINATION SITE PAIN (Sore arm at injection site and pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was taken for cholesterol.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: Chills; Sore shoulder; A spontaneous report was received from a consumer, concerning a 90-year-old male patient, who received Moderna's COVID-19 vaccine and experienced chills /and sore shoulder/myalgia.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 10 Feb 2021, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (lot number unknown) via intramuscular route for COVID-19 infection prophylaxis.   On 10 Feb 2021, after unknown dose of vaccine, the patient experienced chills and sore shoulder. No treatment medication was reported.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the event(s), chills and sore shoulder was considered to be unknown at the time of this report.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vitreous floaters
Clinical narrative: On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced VITREOUS FLOATERS (visual specks in the left eye,Floaters in vision in the left eye). At the time of the report, VITREOUS FLOATERS (visual specks in the left eye,Floaters in vision in the left eye) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient took the second dose on 8Feb2021 in the Left arm, Lot number unknown. No treatment medication were provided  No concomitants were provided   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Follow up received on 8-FEB-2021 updated reporter details, patient demographics, event dates updated.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: redness; itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (itching). At the time of the report, VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included Advil for fever   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching
Clinical narrative: muscle twitching right calf and left eyebrow / constant muscle twitching throughout body including stomach, back, lip; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (muscle twitching right calf and left eyebrow / constant muscle twitching throughout body including stomach, back, lip) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included FISH OIL, LIOTHYRONINE, PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced MUSCLE TWITCHING (muscle twitching right calf and left eyebrow / constant muscle twitching throughout body including stomach, back, lip). At the time of the report, MUSCLE TWITCHING (muscle twitching right calf and left eyebrow / constant muscle twitching throughout body including stomach, back, lip) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included Benadryl 25mg.   Reporter did not allow further contact
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site erythema, Vaccination site induration, Vaccination site nodule, Vaccination site pain
Clinical narrative: Swollen arm; Red arm; Hardness to touch on the arm; Tenderness to touch on the arm; Itchy arm; A knot on the arm; Warm arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE ERYTHEMA (Red arm), VACCINATION SITE INDURATION (Hardness to touch on the arm), VACCINATION SITE PAIN (Tenderness to touch on the arm) and VACCINATION SITE PRURITUS (Itchy arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE ERYTHEMA (Red arm), VACCINATION SITE INDURATION (Hardness to touch on the arm), VACCINATION SITE PAIN (Tenderness to touch on the arm), VACCINATION SITE PRURITUS (Itchy arm), VACCINATION SITE NODULE (A knot on the arm) and VACCINATION SITE WARMTH (Warm arm). At the time of the report, PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE ERYTHEMA (Red arm), VACCINATION SITE INDURATION (Hardness to touch on the arm), VACCINATION SITE PAIN (Tenderness to touch on the arm), VACCINATION SITE PRURITUS (Itchy arm), VACCINATION SITE NODULE (A knot on the arm) and VACCINATION SITE WARMTH (Warm arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Swollen arm; Red arm; Hardness to touch on the arm; Tenderness to touch on the arm; Itchy arm; A knot on the arm; Warm arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE ERYTHEMA (Red arm), VACCINATION SITE INDURATION (Hardness to touch on the arm), VACCINATION SITE PAIN (Tenderness to touch on the arm) and VACCINATION SITE PRURITUS (Itchy arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE ERYTHEMA (Red arm), VACCINATION SITE INDURATION (Hardness to touch on the arm), VACCINATION SITE PAIN (Tenderness to touch on the arm), VACCINATION SITE PRURITUS (Itchy arm), VACCINATION SITE NODULE (A knot on the arm) and VACCINATION SITE WARMTH (Warm arm). At the time of the report, PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE ERYTHEMA (Red arm), VACCINATION SITE INDURATION (Hardness to touch on the arm), VACCINATION SITE PAIN (Tenderness to touch on the arm), VACCINATION SITE PRURITUS (Itchy arm), VACCINATION SITE NODULE (A knot on the arm) and VACCINATION SITE WARMTH (Warm arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Vomiting
Clinical narrative: aching all over; sore arm; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aching all over), PAIN IN EXTREMITY (sore arm) and VOMITING (vomiting) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concomitant products included ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (aching all over), PAIN IN EXTREMITY (sore arm) and VOMITING (vomiting). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (aching all over), PAIN IN EXTREMITY (sore arm) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were provided as antidepressant medication.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Erythema, Pain in extremity, Rash macular
Clinical narrative: CONCERNED; RED BLOTCHES DONT SEEM TO BE GOING AWAY; REDNESS ON HER LEFT ARM; TWO BIG RED BLOTCHES; SORENESS IN LEFT ARM; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (SORENESS IN LEFT ARM), ERYTHEMA (REDNESS ON HER LEFT ARM), RASH MACULAR (TWO BIG RED BLOTCHES), ANXIETY (CONCERNED) and RASH MACULAR (RED BLOTCHES DONT SEEM TO BE GOING AWAY) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included Thyroidectomy, Corneal biopsy (on 2011 and 2013) and Osteopenia. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), VITAMIN D3 and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 1. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (SORENESS IN LEFT ARM). On 07-Feb-2021, the patient experienced ERYTHEMA (REDNESS ON HER LEFT ARM) and RASH MACULAR (TWO BIG RED BLOTCHES). On 17-Feb-2021, the patient experienced ANXIETY (CONCERNED) and RASH MACULAR (RED BLOTCHES DONT SEEM TO BE GOING AWAY). On 07-Feb-2021, PAIN IN EXTREMITY (SORENESS IN LEFT ARM) had resolved. At the time of the report, ERYTHEMA (REDNESS ON HER LEFT ARM), RASH MACULAR (TWO BIG RED BLOTCHES), ANXIETY (CONCERNED) and RASH MACULAR (RED BLOTCHES DONT SEEM TO BE GOING AWAY) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant drug includes prolia  june 2020 was last injection, Citracal with iron, prednisolone eye drops. No treatment was reported.   This case was linked to MOD-2021-090016 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Arm pain in injection site since vaccination; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Arm pain in injection site since vaccination) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced INJECTION SITE PAIN (Arm pain in injection site since vaccination). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, INJECTION SITE PAIN (Arm pain in injection site since vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medication included unspecified high blood pressure medications.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Chills, Dizziness, Feeling of body temperature change, Illness
Clinical narrative: Clumps; ILLNESS; Could not get up from bed; Very dizzy; Cycles of feeling chilly and feeling very hot; Smoke vision; chills; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Clumps), ILLNESS (ILLNESS), MOBILITY DECREASED (Could not get up from bed), DIZZINESS (Very dizzy) and FEELING OF BODY TEMPERATURE CHANGE (Cycles of feeling chilly and feeling very hot) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20 Not clear the last letter) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Type 2 diabetes mellitus. Concomitant products included LISINOPRIL and METFORMIN.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Clumps), ILLNESS (ILLNESS), MOBILITY DECREASED (Could not get up from bed), DIZZINESS (Very dizzy), FEELING OF BODY TEMPERATURE CHANGE (Cycles of feeling chilly and feeling very hot), VISUAL IMPAIRMENT (Smoke vision) and CHILLS (chills). At the time of the report, ADVERSE REACTION (Clumps), ILLNESS (ILLNESS), MOBILITY DECREASED (Could not get up from bed), DIZZINESS (Very dizzy), FEELING OF BODY TEMPERATURE CHANGE (Cycles of feeling chilly and feeling very hot), VISUAL IMPAIRMENT (Smoke vision) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included paracetamol.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Visual impairment
Clinical narrative: Clumps; ILLNESS; Could not get up from bed; Very dizzy; Cycles of feeling chilly and feeling very hot; Smoke vision; chills; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Clumps), ILLNESS (ILLNESS), MOBILITY DECREASED (Could not get up from bed), DIZZINESS (Very dizzy) and FEELING OF BODY TEMPERATURE CHANGE (Cycles of feeling chilly and feeling very hot) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20 Not clear the last letter) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Type 2 diabetes mellitus. Concomitant products included LISINOPRIL and METFORMIN.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Clumps), ILLNESS (ILLNESS), MOBILITY DECREASED (Could not get up from bed), DIZZINESS (Very dizzy), FEELING OF BODY TEMPERATURE CHANGE (Cycles of feeling chilly and feeling very hot), VISUAL IMPAIRMENT (Smoke vision) and CHILLS (chills). At the time of the report, ADVERSE REACTION (Clumps), ILLNESS (ILLNESS), MOBILITY DECREASED (Could not get up from bed), DIZZINESS (Very dizzy), FEELING OF BODY TEMPERATURE CHANGE (Cycles of feeling chilly and feeling very hot), VISUAL IMPAIRMENT (Smoke vision) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included paracetamol.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: full body rash; This spontaneous case was reported by a health care professional and describes the occurrence of RASH (full body rash) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (Penicillin).    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (full body rash). At the time of the report, RASH (full body rash) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Feeling abnormal, Influenza like illness
Clinical narrative: swelling from his elbow to wrist; now his right hand is swollen as well; hot to the touch; Can't use his hand; He has pain in every joint of his hand and fingers.; sore arm; felt like he had flu like symptoms; He was tired and had chills; He was tired and had chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (felt like he had flu like symptoms), JOINT SWELLING (swelling from his elbow to wrist), PERIPHERAL SWELLING (now his right hand is swollen as well) and VACCINATION SITE WARMTH (hot to the touch) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Obesity and Atrial fibrillation. Concurrent medical conditions included Hypertension and Penicillin allergy. Concomitant products included LOSARTAN POTASSIUM (LOSARTAN "AGP") and SPIRONOLACTONE for an unknown indication.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (felt like he had flu like symptoms), CHILLS (He was tired and had chills) and FATIGUE (He was tired and had chills). On 07-Feb-2021, the patient experienced JOINT SWELLING (swelling from his elbow to wrist), PERIPHERAL SWELLING (now his right hand is swollen as well), VACCINATION SITE WARMTH (hot to the touch), FEELING ABNORMAL (Can't use his hand) and ARTHRALGIA (He has pain in every joint of his hand and fingers.). At the time of the report, PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (felt like he had flu like symptoms), JOINT SWELLING (swelling from his elbow to wrist), PERIPHERAL SWELLING (now his right hand is swollen as well), VACCINATION SITE WARMTH (hot to the touch), FEELING ABNORMAL (Can't use his hand), CHILLS (He was tired and had chills), FATIGUE (He was tired and had chills) and ARTHRALGIA (He has pain in every joint of his hand and fingers.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: negative Negative. On an unknown date, X-ray: negative Negative.         No treatment was reported. Action taken in response to mRNA-1273 was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: TCR